Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to ...

A study published in Drug and Alcohol Dependence suggests that co-using alcohol and cannabis does not produce additional ...

After hours: January 31 at 7:15:45 PM EST ...

Cingulate Inc. (NASDAQ:CING – Free Report) – Equities research analysts at HC Wainwright issued their Q4 2024 EPS estimates for shares of Cingulate in a report issued on Thursday, January 30th.

Regional glucose metabolic rates in the posterior cingulate gyri and in the right middle temporal gyrus were significantly correlated with temporal orientation, and the glucose metabolic rate in the ...

These oscillations have many functions in the brain ... caused by psilocybin may indicate that the anterior cingulate cortex transmits and receives less information to and from faraway brain ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Methods: Here, we use RNA sequencing to lay the groundwork for translational studies of molecular rhythms through a sex-specific, cross species comparison of transcriptomic rhythms between the mouse ...